Sonablate is a Charlotte-based company founded in 1990 that specializes in designing and manufacturing minimally invasive ablation systems for the treatment of prostate disease. Their ultrasound technology, known as HIFU, uses non-ionizing ultrasonic energy to heat tissue, allowing physicians to create personalized treatment plans for each patient. Sonablate's laparoscopic invasive HIFU surgical ablation system, integrated multi-transducer technology, and ultrasound-based imaging and assessment technology provide effective clinical interventions while preserving the quality of life for patients. Their mission is to expand their HIFU technologies to treat a range of urological indications, focusing on balancing treatment effectiveness and quality of life.